After recording the most infectious mosquito bites globally – estimated at 1,500 per person a year – Uganda’s Apac district is rolling out the malaria vaccine to babies and toddlers. 13 June 2025 by John Agaba Dr James Odongo sat eating greens at a restaurant in Apac district in northern Uganda when his phone rang. The Ministry of Health had…
Making sure all at-risk children can access the vaccine is proving the key to a steeply falling prevalence of the chronic infection. 16 June 2025 by Hudson Kuteesa Two years ago, Clementine*, 32, visited the University Teaching Hospital of Kigali (CHUK). She was two-and-a-half months pregnant, and hadn’t planned to visit the health facility so…
French pharmaceutical group Pierre Fabre Laboratories has acquired the worldwide rights to two next-generation therapies for non-small cell lung cancer (NSCLC), strengthening its oncology research and development pipeline. Pierre Fabre Laboratories announced today the acquisition of global rights to PFL-721 and PFL-241—formerly STX-721 and STX-241—from Antares Therapeutics, a spin-out of U.S.-based Scorpion Therapeutics. The two…